Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | hace 1039
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | hace 783
European Shares Set For Mixed Open

European Shares Set For Mixed Open

European stocks are seen opening broadly higher on Monday, though French markets may drift lower after the National Assembly voted down dual proposals to tax the ultra-wealthy, dealing a blow to left-wing lawmakers who had made fiscal reform their condition for passing the budget.
RTTNews | hace 2h 7min
Australian Market Slashes Early Losses In Mid-market

Australian Market Slashes Early Losses In Mid-market

The Australian stock market is slashing its early losses in mid-market trading on Monday, but extending the losses in the previous four sessions, despite the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is staying below the 8,850 level, with weakness in materials stocks partially offset by gains in energy, financial and technology stocks.
RTTNews | hace 4h 20min
Asian Markets Track Wall Street Higher

Asian Markets Track Wall Street Higher

Asian stock markets are trading mostly higher on Monday, following the broadly positive cues from Wall Street on Friday, as a temporary tariff truce materialized between the U.S. and China wherein China agreed to buy more U.S. energy. This gave fresh optimism about smooth trade relations between the two major oil consumers of the world. Asian markets closed mixed on Friday.
RTTNews | hace 4h 26min
Sensex, Nifty Likely To Open On Cautious Note

Sensex, Nifty Likely To Open On Cautious Note

Indian shares look set to open on a subdued note Monday after having snapped their four-week winning streak last week due to profit taking after recent gains to record highs.
RTTNews | hace 5h 8min